
CureVac N.V. CVAC
Quarterly report 2022-Q2
added 08-18-2022
CureVac N.V. EV/EBITDA Ratio 2011-2026 | CVAC
Annual EV/EBITDA Ratio CureVac N.V.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -7.74 | -150 | - | - | - | - | - | - | - | - | - |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -7.74 | -150 | -78.8 |
EV/EBITDA Ratio of other stocks in the Biotechnology industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Compugen Ltd.
CGEN
|
-7.07 | $ 2.76 | -8.91 % | $ 258 M | ||
|
FSD Pharma
HUGE
|
-0.271 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
-0.591 | - | 2.43 % | $ 254 M | ||
|
Coherus BioSciences
CHRS
|
-1.86 | $ 1.56 | -4.29 % | $ 183 M | ||
|
Happiness Biotech Group Limited
HAPP
|
-0.984 | - | 1.35 % | $ 17.8 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
11.2 | $ 16.91 | -2.25 % | $ 790 M | ||
|
AgeX Therapeutics
AGE
|
-0.164 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
595 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
4.22 K | - | 2.54 % | $ 160 B | ||
|
AstraZeneca PLC
AZN
|
3.06 | - | - | $ 96.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
-0.593 | $ 7.47 | -4.6 % | $ 205 M | ||
|
Athira Pharma
ATHA
|
0.0485 | - | - | $ 269 M | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
8.55 | - | 0.74 % | $ 768 M | ||
|
Galera Therapeutics
GRTX
|
2.25 | - | -32.59 % | $ 7.61 M | ||
|
Eton Pharmaceuticals
ETON
|
187 | $ 29.79 | -0.58 % | $ 802 M | ||
|
Exelixis
EXEL
|
18.1 | $ 50.0 | -2.15 % | $ 13.6 B | ||
|
Midatech Pharma plc
MTP
|
0.204 | - | -18.52 % | $ 27.3 M | ||
|
Fortress Biotech
FBIO
|
-1.74 | $ 2.38 | 3.7 % | $ 66.4 M | ||
|
Forte Biosciences
FBRX
|
-3.97 | $ 22.5 | -6.09 % | $ 291 M | ||
|
Fennec Pharmaceuticals
FENC
|
-26.6 | $ 9.75 | 5.52 % | $ 279 M | ||
|
AbCellera Biologics
ABCL
|
-6.16 | $ 4.08 | -7.39 % | $ 1.22 B | ||
|
Autolus Therapeutics plc
AUTL
|
-2.4 | $ 1.59 | 0.14 % | $ 423 M | ||
|
Институт стволовых клеток человека
ISKJ
|
14 | - | - | - | ||
|
BioNTech SE
BNTX
|
-12.2 | $ 89.66 | -2.53 % | $ 21.7 B | ||
|
Checkmate Pharmaceuticals
CMPI
|
-0.0315 | - | - | $ 231 M | ||
|
Galectin Therapeutics
GALT
|
-1.92 | $ 2.22 | -5.74 % | $ 142 M | ||
|
Advaxis
ADXS
|
-82.4 | - | -9.65 % | $ 45.9 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
0.0726 | $ 3.36 | -3.72 % | $ 5.53 M | ||
|
Aeterna Zentaris
AEZS
|
-0.963 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.27 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.546 | - | - | $ 26.5 M | ||
|
Gilead Sciences
GILD
|
16.9 | $ 129.82 | -1.7 % | $ 161 B | ||
|
AIkido Pharma
AIKI
|
-45.5 | - | 1.93 % | $ 17.4 M | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
-1 | $ 0.72 | -2.34 % | $ 32.9 M | ||
|
Akero Therapeutics
AKRO
|
-4.64 | - | - | $ 3.67 B | ||
|
Esperion Therapeutics
ESPR
|
19.2 | $ 3.13 | 0.16 % | $ 651 M | ||
|
Aptose Biosciences
APTO
|
1.65 K | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-1.56 | - | -39.0 % | $ 4.57 M | ||
|
Akouos
AKUS
|
-1.13 | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
-3.38 | - | -0.23 % | $ 916 M | ||
|
AlloVir
ALVR
|
1.19 | - | 4.14 % | $ 49.1 M | ||
|
Allakos
ALLK
|
-1.56 | - | - | $ 28.6 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-316 | $ 21.7 | 0.6 % | $ 2.76 B | ||
|
Allena Pharmaceuticals
ALNA
|
0.298 | - | 3.16 % | $ 1.9 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-20.4 | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
-1.19 | - | - | $ 10.1 M |